Type of autoinflammatory diseases | Responding proteins | Functions | Corresponding diseases with the similar signaling |
---|---|---|---|
Inflammasomopathies | |||
CAPS | Cryopyrin/NLRP3 | PRR for ROS, K+ efflux, cathepsin B detection | Metabolic syndrome: |
Gout [42] | |||
Atherosclerosis [43] | |||
Type 2 diabetes [44] | |||
Neurodegenerative disease: | |||
Parkinson’s disease [47] | |||
Amyotrophic lateral sclerosis [48] | |||
Multiple sclerosis [49] | |||
Infections and aberrant inflammatory responses: | |||
Ischemic diseases: | |||
Myocardial infarction [52] | |||
Stroke [53] | |||
NAIAD | NLRP1 | PRR against Anthrax toxin detection | Infections and aberrant inflammatory responses: |
Anthrax lethal toxin [54] | |||
Neurodegenerative disease: | |||
Alzheimer’s disease [46] | |||
Ischemic diseases: | |||
Stroke [53] | |||
NLRP12-AD | NLRP12 | PRR for Yersinia pestis detection | Infections and aberrant inflammatory responses: |
Yersinia pestis [55] | |||
Plasmodium chabaudi [56] | |||
NF-κB inhibition | Regulation of inflammation: | ||
Salmonella typhimurium [57] | |||
Brucella abortus [58] | |||
TRAPS | TNFRSF1A | TNF receptor | Infections and aberrant inflammatory responses: |
Tumor necrosis factor [59] | |||
APLAID | PLCγ2 | Cleavage PIP to DAG | Immunodeficiency: |
Common variable immunodeficiency [60] | |||
PLCγ2-associated antibody deficiency and immune dysregulation syndrome (PLAID) [60] | |||
Familial cold autoinflammatory syndrome 3 [60] | |||
Neurodegenerative disease: | |||
Lewy body dementia [62] | |||
Frontotemporal dementia [62] | |||
FMF | Pyrin | Virulence sensor | Infections and aberrant inflammatory responses: |
Yersinia pestis infection [63] | |||
PFIT | WDR1 | Actin assembly, leukocyte migration | Infections and aberrant inflammatory responses: |
Listeria monocytogenes dissemination [64] | |||
PAAND | Pyrin | Virulence sensor | Infections and aberrant inflammatory responses: |
Yersinia pestis infection [63] | |||
PAPA syndrome | PSTPIP1/CD2BP1 | Pyrin regulation | Immunodeficiency: |
Common variable immunodeficiency [65] | |||
MKD | MVK | Lipid metabolism | Metabolic syndrome: |
Atherosclerosis [66] | |||
NLRC4 inflammasomopathies | NLRC4 | PRR for flagellin detection | Infections and aberrant inflammatory responses: |
Pseudomonas aeruginosa infection [67] | |||
Macrophage activation syndrome (MAS) [68] | |||
Relopathies | |||
BS/EOS | NOD2 | PRR for MDP | Infections and aberrant inflammatory responses: |
Mycobacterium tuberculosis infection [69] | |||
HA20 | A20/TNFAIP3A | Deubiquitinating for NF-κB regulation | Infections and aberrant inflammatory responses: |
Systemic lupus erythematosus (SLE) [70] | |||
Rheumatoid arthritis [71] | |||
IAALUCD | LUBAC | Ubiquitinating for NF-κB regulation | Infections and aberrant inflammatory responses: |
HOIL-1/ RBCK1 | Salmonella enterica infection [72] | ||
HOIP/RNF31 | Legionella pneumophila infection [72] | ||
SHARPIN | Shigella flexneri infection [72] | ||
ORAS | OTULIN | Deubiquitinating for NF-κB regulation | Infections and aberrant inflammatory responses: |
Salmonella Typhimurium infection [73] | |||
IL-1 receptor-related autoinflammatory diseases: | |||
DIRA | IL1RN | IL-1 receptor inhibitor | Infections and aberrant inflammatory responses: |
Inflammasomopathies [74] | |||
Interferonopathies | |||
AGS | RNASEH2 | RNase activity against viral RNA | Infections and aberrant inflammatory responses: |
Cervical cancer via human papilloma virus [77] | |||
SAMHD1 | dNTPase activity against viral RNA/DNA | Epstein-Barr virus infection [78] | |
Human immunodeficiency virus infection [79] | |||
ADAR1 | Viral RNA processing | Hepatitis B virus infection [80] | |
Marburg and Ebola virus [81] | |||
MDA5/IFIH1 | PRR for viral RNA detection | Paramyxovirus infection [82] | |
Picornavirus infection [83] | |||
SAVI | STING/TMEM173 | PRR for viral DNA/RNA detection | Infections and aberrant inflammatory responses: |
SLE and other autoimmune diseases [76] | |||
ANCA-associated vasculitis [84] | |||
Herpes simplex virus infection [85] | |||
COPA syndrome | αCOP | Transport vesicles between Golgi to ER | Infections and aberrant inflammatory responses: |
Interstitial lung disease [86] | |||
Capillaritis [87] | |||
PRAAS/NNS/CANDLE | PSMB3,4,8,9 | Proteasome for antigen processing | Infections and aberrant inflammatory responses: |
Cytomegalovirus infection [89] | |||
Hepatitis B virus infection [90] | |||
Influenza virus infection [91] | |||
POMP | Proteasome chaperone | Infections and aberrant inflammatory responses: | |
Psoriasis [92] | |||
Human papilloma virus infection [93] | |||
SMS | MDA5/IFIH1 | PRR for viral RNA detection | Infections and aberrant inflammatory responses: |
Paramyxovirus infection [82] | |||
Picornavirus infection [83] | |||
RIG-I | PRR for viral RNA detection | Infections and aberrant inflammatory responses: | |
SLE and other autoimmune diseases [95] | |||
Paramyxovirus infection [83] |